Document:

Form of Directors Stock Appreciation Rights Agreement

 Exhibit 10.5 
 DIRECTORS STOCK APPRECIATION RIGHTS AGREEMENT 
 Non-transferable 
 G R A N T T O 
 [                        ] 
 (“Grantee”) 
 by Assurant, Inc. (the “Company”) of 
 Stock Appreciation Rights with respect to 
 [                    ] 
 shares of its common stock, $0.01 par value (the “SARs”), 
 having an exercise price of $
[            ] per share (the “Exercise Price”), 
 pursuant to and
subject to the provisions of the Assurant, Inc. Long Term Equity Incentive Plan (the “Plan”), and the terms and conditions set forth on the following page (the “Terms and Conditions”). 
 The SARs are fully vested and exercisable as of the Grant Date, but shares of Stock issuable upon exercise of the SARs are subject to a minimum holding
period as provided in Section 5 of the Terms and Conditions. 
 IN WITNESS WHEREOF, Assurant, Inc., acting by and through its duly
authorized officers, has caused this Agreement to be executed as of the Grant Date. 
  

			
	ASSURANT, INC.
		
	By:	 	 
		 	[Authorized Officer]

  

	
	Grant Date: [                    ]
	
	  
	Accepted by Grantee:

 TERMS AND CONDITIONS 
 1. Grant of SARs. The Company hereby grants to the Grantee named on page 1 hereof (“Grantee”), under the Plan and on the terms and conditions set forth in this Directors Stock Appreciation Rights Agreement (this
“Agreement”), stock appreciation rights with respect to the number of Shares indicated on page 1 of the Company’s Common Stock, at the exercise price per Share set forth on page 1 (the “SARs”). 
 2. Defined Terms. Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Plan. 

3. Exercise Price and Benefit. The Exercise Price of each SAR is equal to the Fair Market Value of a share of Common Stock on the Grant Date.
The SARs entitle Grantee to receive from the Company upon exercise that number of shares of the Company’s Common Stock (the “Shares”) having a Fair Market Value, as of the date of such exercise, equal to the amount obtained by
multiplying (a) the excess, if any, of the Fair Market Value of a share of Common Stock on the date of such exercise over the Exercise Price by (b) the number of shares with respect to which the SAR shall have been exercised. For purposes
of computing the number of Shares that Grantee has a right to acquire by any such exercise, fractional Shares shall be rounded to the nearest whole Share. 
 4. Term of and Exercise of SARs. The term of the SARs is a period of five years, expiring at 5:00 p.m., Eastern Time, on the fifth anniversary of the Grant Date (the “Expiration Date”). The SARs are
fully vested and exercisable as of the Grant Date, and shall be exercised by written notice directed to the Secretary of the Company or his or her designee at the address and in the form specified by the Secretary from time to time. If the person
exercising a SAR is not Grantee, such person shall also deliver with the notice of exercise appropriate proof of his or her right to exercise the SAR. Notwithstanding the foregoing, to the extent not previously exercised, the SARs shall be
automatically exercised (and shall thereupon expire) on the earlier of (i) the first anniversary of Grantee’s termination as a director of the Company for any reason, or (ii) the Expiration Date. The Board may in its discretion compel
the early exercise of the SARs in order to facilitate any reorganization, recapitalization, or other need of the Company. In requiring such mandatory exercise, the Board in its discretion may select which SARs shall be exercised. 
 5. Minimum Holding Period. The Shares issuable upon exercise of the SARs may not be sold, transferred, exchanged, assigned, pledged, hypothecated
or otherwise encumbered to or in favor of any party other than the Company, and may not be subject to any lien, obligation or liability of Grantee to any other party other than the Company, until the earlier of (i) the fifth anniversary of the
Grant Date, or (ii) Grantee’s termination as a director of the Company for any reason (the “Minimum Holding Period”). 
 6. Delivery of Shares. Any certificate issued in respect of Shares issuable upon exercise of the SARs will be registered in the name of Grantee as of the date of exercise. Any certificate issued during the Minimum Holding Period with
respect to such Shares shall be registered in the name of Grantee and shall bear a legend in substantially the following form: 
 “This
certificate and the shares of stock represented hereby are subject to the terms and conditions (including restrictions against transfer) contained in a Directors Stock Appreciation Rights Agreement between the registered owner of the shares
represented hereby and Assurant, Inc. Release from such terms and conditions shall be made only in accordance with the provisions of such Agreement, copies of which are on file in the offices of Assurant, Inc.” 
 Stock certificates for the Shares, without the first above legend, may be delivered to Grantee or Grantee’s designee upon request of Grantee after the expiration of
the Minimum Holding Period. If the Shares are issued in uncertificated form, during the Minimum Holding Period the Company shall instruct the transfer agent not to permit the transfer of the Shares until the expiration of the Minimum Holding Period.

 7. Voting and Dividend Rights. Grantee, as beneficial owner of the Shares issued upon exercise of the SARs, shall have full voting
and dividend rights with respect to the Shares during and after the Minimum Holding Period. 
 8. Beneficiary Designation. Grantee
may, in the manner determined by the Board, designate a beneficiary to exercise the rights of Grantee hereunder and to receive any distribution with respect to the SARs upon Grantee’s death. A beneficiary, legal guardian, legal representative,
or other person claiming any rights hereunder is subject to all terms and conditions of this Agreement, the Plan, and any additional restrictions deemed necessary or appropriate by the Board. If no beneficiary has been designated or no designated
beneficiary survives Grantee, the SARs may be exercised by the legal representative of Grantee’s estate, and payment shall be made to Grantee’s estate. Subject to the foregoing, a beneficiary designation may be changed or revoked by
Grantee at any time provided the change or revocation is filed with the Board. 
 9. Limitation of Rights. The SARs do not confer to
Grantee or Grantee’s beneficiary designated pursuant to Section 8 any rights of a shareholder of the Company unless and until Shares are in fact issued to such person in connection with the exercise of the SARs. Nothing in this Agreement
shall confer upon Grantee any right to continue as a director of the Company. 
 10. Restrictions on Transfer and Pledge. The SARs may
not be pledged, encumbered, or hypothecated to or in favor of any party other than the Company, nor shall they be subject to any lien, obligation, or liability of Grantee to any other party other than the Company. The SARs are not assignable or
transferable by Grantee other than by will or the laws of descent and distribution. The SARs may be exercised during the lifetime of Grantee only by Grantee. 
 11. Restrictions on Issuance of Shares. If at any time the Committee shall determine in its discretion that registration, listing, or qualification of the Shares covered by the SARs upon any Exchange or under
any foreign, federal, or local law or practice, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition to the exercise of the SARs, the SARs may not be exercised in whole or in part unless and until
such registration, listing, qualification, consent, or approval shall have been effected or obtained free of any conditions not acceptable to the Committee. 
 12. Plan Controls. The terms contained in the Plan are incorporated into and made a part of this Agreement, and this Agreement shall be governed by and construed in accordance with the Plan. In the event of any
actual or alleged conflict between the provisions of the Plan and the provisions of this Agreement, the provisions of the Plan shall be controlling and determinative. 
 13. Successors. This Agreement shall be binding upon any successor of the Company, in accordance with the terms of this Agreement and the Plan. 
 14. Severability. If any one or more of the provisions contained in this Agreement is invalid, illegal or unenforceable, the other provisions of
this Agreement will be construed and enforced as if the invalid, illegal, or unenforceable provision had never been included. 
 15.
Notice. Notices and communications under this Agreement must be in writing and either personally delivered or sent by registered or certified United States mail, return receipt requested, postage prepaid. Notices to the Company must be
addressed to: 
 Assurant, Inc. 
 One Chase Manhattan Plaza, 41st Floor 
 New York, New York 10005 
 Attn: Secretary, 
 or any other address designated by the
Company in a written notice to Grantee. Notices to Grantee will be directed to the address of Grantee then currently on file with the Company, or to any other address provided by Grantee in a written notice to the Company.Form of Restricted Stock Agreement for Executive Officers

 Exhibit 10.6 
 R E S T R I C T E D   S T O C K   A G R E E M E N T 
 FOR EXECUTIVE OFFICERS 

[20__] Award 
 Non-transferable 
 G R A N T T O 
 [                    ] 
 (“Grantee”) 
 by Assurant, Inc. (the “Company”) of 
 [                    ] 
 shares of its common stock, $0.01 par value (the “Shares”), 
 pursuant to and subject to the provisions of the Assurant, Inc. Long Term Equity Incentive Plan (the “Plan”), and to the terms and conditions set forth on the following page (the “Terms and
Conditions”). 
 Unless sooner vested in accordance with the Plan or Section 4 of the Terms and Conditions, the restrictions
imposed under Section 3 of the Terms and Conditions will expire as to the following number or percentage of the Shares awarded hereunder, on the following respective dates: 
  

			
	 Number or
 Percentage of Shares
	  	Date of Expiration
of Restrictions
		  	

 Additional conditions: [Specify any additional vesting or other conditions.] 
 IN WITNESS WHEREOF, Assurant, Inc., acting by and through its duly authorized officers, has caused this Agreement to be executed as of the Grant Date.

  

			
	ASSURANT, INC.
		
	By:	 	 
		 	Chief Executive Officer

  

			
	Grant Date:
[                        ]
		
	Accepted by Grantee:	 	 
		 	(Name)

 TERMS AND CONDITIONS 
 1.
Grant of Shares. Assurant, Inc. (the “Company”) hereby grants to the Grantee named on page 1 (“Grantee”), subject to the restrictions and the other terms and conditions set forth in the Plan and in this award agreement
(this “Agreement”), the number of shares indicated on page 1 of the Company’s $0.01 par value common stock (the “Shares”). 
 2.
Defined Terms. Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Plan. 
 3.
Restrictions. The Shares are subject to each of the following restrictions. “Restricted Shares” mean those Shares that are subject to the restrictions imposed hereunder which restrictions have not then expired or terminated.
Restricted Shares may not be sold, transferred, exchanged, assigned, pledged, hypothecated or otherwise encumbered. Upon Grantee’s Termination of Employment, Grantee shall forfeit all of Grantee’s right, title and interest in and to the
Restricted Shares as of the date of the Termination of Employment (after giving effect to any lapsed restrictions under Section 4), and such Restricted Shares shall revert to the Company. The restrictions imposed under this Section shall apply
to all shares of the Company’s common stock or other securities issued with respect to Restricted Shares hereunder in connection with any merger, reorganization, consolidation, recapitalization, stock dividend, or other change in corporate
structure affecting the common stock of the Company. 
 4. Expiration and Termination of Restrictions. The restrictions imposed under Section 3
will expire on the earliest to occur of the following (the period prior to such expiration being referred to herein as the “Restricted Period”): 
 (a) As to the numbers or percentages of the Shares specified on page 1, on the respective dates specified on page 1; or 
 (b) As to all of the Restricted Shares, upon a Change of Control; or 
 (c) Upon the date of Grantee’s
death or Disability, the number of Restricted Shares determined by (i) multiplying the aggregate number of Shares originally subject to this Agreement as specified on page 1 by a fraction, the numerator of which is the number of completed
calendar months from the Grant Date to the date of Grantee’s death or Disability, as the case may be, and the denominator of which is the number of full months during the Restricted Period, and (ii) subtracting from such amount that number
of Shares which otherwise have become vested prior to the date of Grantee’s death or Disability, as the case may be. For computing purposes, fractional shares shall be rounded to the nearest whole Share. 
 (d) In connection with the Retirement of a Participant, to the extent permitted by the terms of the Plan, the Committee, or the Chief Executive Officer
with regard to non-Section 16 officers, may at any time, in its sole discretion, accelerate or waive, in whole or in part, the foregoing restrictions, and in connection therewith may impose such terms and conditions as it deems necessary or
advisable, including requiring that the Participant enter into a release of claims and an agreement containing restrictive covenants. 
 5. Delivery of
Shares. Any certificate issued in respect of the Shares shall be registered in the name of Grantee as of the Grant Date and may be held by the Company during the Restricted Period. If a certificate for Restricted Shares is issued, such
certificate shall be registered in the name of Grantee and shall bear a legend in substantially the following form (in addition to any legend required under applicable state securities laws): 
 “This certificate and the shares of stock represented hereby are subject to the terms and conditions (including forfeiture and restrictions against transfer)
contained in a Restricted Stock Agreement between the registered owner of the shares represented hereby and Assurant, Inc. Release from such terms and conditions shall be made only in accordance with the provisions of such Agreement, copies of which
are on file in the offices of Assurant, Inc.” 
 Stock certificates for the Shares, without the above legend, may be delivered to Grantee or
Grantee’s designee upon request after the expiration of the Restricted Period. If the Shares are issued in uncertificated form, during the Restricted Period the Company shall instruct the transfer agent not to permit the transfer of the
Restricted Shares until the expiration of the Restricted Period. 
 6. Voting and Dividend Rights. Grantee, as beneficial owner of the Shares, shall
have full voting and dividend rights with respect to the Shares during and after the Restricted Period. If Grantee forfeits any rights he may have under this Agreement in accordance with Sections 3 and 4, Grantee shall no longer have any rights as a
shareholder with respect to the Restricted Shares or any interest therein, and Grantee shall no longer be entitled to receive dividends on such stock. In the event that for any reason Grantee shall have received dividends upon such stock after such
forfeiture, Grantee shall repay to the Company an amount equal to such dividends. 
 7. No Right of Continued Service. Nothing in this Agreement shall
confer upon Grantee any right to continue in the service of the Company or any Affiliate. 
 8. Payment of Taxes. 
 (a) Upon issuance of the Shares hereunder, Grantee may make an election to be taxed under Section 83(b) of the Code. To effect such election,
Grantee must file an appropriate election with the Internal Revenue Service within thirty (30) days after award of the Shares and otherwise in accordance with applicable Treasury Regulations. 
 (b) In accordance with such procedures as the Committee establishes, at such time as any amount related to the Shares becomes includable in
Grantee’s gross income for tax purposes (the “Tax Date”), the Company will withhold a number of Shares having a Fair Market Value on the date of withholding equal to the minimum amount required by law to be withheld with respect to
federal, state and local taxes of any kind. Alternatively, if Grantee provides prior written notice to the Company, Grantee may, no later than the Tax Date, pay to the Company such amounts required by law to be withheld or make other arrangements
satisfactory to the Committee regarding the payment of such amounts. Such written notice shall be directed to the Secretary of the Company or his or her designee at the address and in the form specified by the Secretary from time to time, at least
thirty (30) days prior to the Tax Date, unless otherwise determined by the Company in its sole discretion. The obligations of the Company under this Agreement shall be conditioned on such withholding or other payment or arrangements, and the
Company, and, where applicable, its Affiliates will, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to Grantee. 
 9. Plan Controls. The terms contained in the Plan are incorporated into and made a part of this Agreement, and this Agreement shall be governed by and construed in accordance with the Plan. In the event of any
actual or alleged conflict between the provisions of the Plan and the provisions of this Agreement, the provisions of the Plan shall be controlling and determinative. 
 10. Successors. This Agreement shall be binding upon any successor of the Company, in accordance with the terms of this Agreement and the Plan. 
 11. Severability. If any one or more of the provisions contained in this Agreement are invalid, illegal, or unenforceable, the other provisions of this Agreement will be construed and enforced as if the
invalid, illegal or unenforceable provision had never been included. 
 12. Notice. Notices and communications under this Agreement must be in writing
and either personally delivered or sent by registered or certified United States mail, return receipt requested, postage prepaid. Notices to the Company must be addressed to: 
 Assurant, Inc. 
 One Chase Manhattan Plaza, 41st Floor 
 New York, New York 10005 
 Attn: Secretary 
 or any other address designated by the Company in a written
notice to Grantee. Notices to Grantee will be directed to the address of Grantee then currently on file with the Company, or to any other address given by Grantee in a written notice to the Company.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00145-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00145-of-00352.parquet"}]]